PHOENIX, Sept. 14,
2022 /PRNewswire/ -- SenesTech, Inc. (NASDAQ: SNES),
a developer of proprietary technologies for managing animal pest
populations through fertility control, announced today that it will
be participating in the Lytham Partners Fall 2022 Investor
Conference taking place virtually on September 28-29, 2022.
Company Webcast
The Company's webcast
presentation will be available for viewing at 9:00am ET on
Wednesday, September 28, 2022, on the
Company's website or
https://wsw.com/webcast/lytham6/snes/2052765. The webcast
will also be archived and available for replay.
1x1 Meetings
Management will be participating in
virtual one-on-one meetings throughout the event. To arrange a
meeting with management, please contact Lytham
Partners at 1x1@lythampartners.com or register
at
https://www.lythampartners.com/fall2022invreg/.
About SenesTech
We are "The Pest Control
Difference" for the 21st century. We are rodent fertility control
specialists fueled by our passion to create a healthy environment
by virtually eliminating rodent pest populations. We keep an
inescapable truth in mind: 2 rats and their descendants can be
responsible for the birth of up to 15,000 pups in a year. We
invented ContraPest, the only U.S. EPA-registered
contraceptive for male and female rats. ContraPest
fits seamlessly into all integrated pest management programs,
greatly improving the overall goal of effective rat management. We
strive for clean cities, efficient businesses, and happy households
– with a product that was designed to be effective and sustainable
without killing rats. At SenesTech, we don't just
eliminate rats. We make a better world.
For more information visit https://senestech.com/ and
https://contrapeststore.com.
Safe Harbor Statement
The foregoing paragraphs contain forward-looking
statements that involve estimates, assumptions, risks and
uncertainties. Any statements about our expectations, beliefs,
plans, objectives, assumptions or future events or performance are
not historical facts and may be forward-looking. "Forward-looking
statements" may be preceded by words such as "may," "future,"
"plan" or "planned," "will," "should," "expected," "anticipates,"
"continue," "eventually," "believes," or "projected."
Forward-looking statements include statements concerning the
potential impact and effects of the COVID-19 pandemic on the
Company's business, results of operations and financial
performance; any measures the Company has and may take in response
to COVID-19 and any expectations the Company may have with respect
thereto; the Company's strategy and target marketing and markets;
continuing the Company's vision; expected benefits of the Company's
initiatives and continuation of those initiatives; deployment of
the Company's product; the continuation or expansion of the use of
ContraPest; demand for ContraPest; the Company's expectation
regarding costs, expenses and cash and continuing its cost
improvement plan; future financial results; and the Company's
execution of its strategic business plan.
CONTACT:
Investor: Robert Blum, Lytham
Partners, LLC, 602-889-9700, senestech@lythampartners.com
Company: Tom Chesterman, Chief
Financial Officer, SenesTech, Inc., 928-779-4143
View original content to download
multimedia:https://www.prnewswire.com/news-releases/senestech-to-participate-in-the-lytham-partners-fall-2022-investor-conference-301623746.html
SOURCE SenesTech, Inc.